The new vending machines have a slightly larger footprint thanks to an additional generator module on the side. That’s where ...

KING OF PRUSSIA, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) today announced that it will host an Investor Day on Wednesday, March 19, in Philadelphia, PA. The event will ...

Vertex announced that the United Kingdom Medicines and Healthcare products Regulatory Agency has granted approval for ALYFTREK, a once-daily next-in-class triple combination cystic fibrosis ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

The assessment showed that Trinasolar Vertex S+ 500W+ modules can reduce the structure cost by up to 12.01%. The structure cost for the four PV modules was $29,936, $30,663, $33,936 and $30,542 ...

Hydrogen nano-clusters at low temperatures display 'superfluidity'—a quantum state of frictionless flow only previously observed in helium. The new research is published in Science Advances by ...

Hydrogen and methane breath tests (HMBT) are a noninvasive diagnostic tool commonly employed to evaluate small intestinal bacterial overgrowth (SIBO) and issues with carbohydrate malabsorption ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Researchers from Johannes Gutenberg University Mainz have developed water-splitting catalysts that are both cost-effective and efficient for hydrogen production. The efficiency of these catalysts ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.